Wong Ee Vin



Ee Vin is a Director of Icon Law. He has strong corporate finance and equity capital markets experience and a focus on venture debt, private credit, funds, alternative investment products, and venture capital. Ee Vin has assisted a broad range of clients with their legal matters, including family offices, venture capital funds, listed companies, and start-ups, often in transactions spanning across Singapore and other Southeast Asian countries such as Indonesia, Vietnam and the Philippines.


Ee Vin commenced legal practice in 2017, and worked at boutique and international law firms prior to joining the former Singapore member firm of the ZICO Law Network in September 2019. Ee Vin was recognised as a “key lawyer” by the Legal 500 during his time as Senior Associate at said firm.

Ee Vin regularly writes legal articles on legal or corporate matters in Singapore and the Southeast Asian region, some of which are accessible on our website.

Ee Vin graduated from the Singapore Management University with a Bachelor of Law (Cum Laude) in 2016, and is also a candidate for the Chartered Financial Analyst program.

  • January 2023 - present: Director, Icon Law LLC
  • October 2022 – December 2022: Senior Associate, Icon Law LLC
  • September 2019– October 2022: Senior Associate, Insights Law LLC / ZICO Insights Law LLC
  • February 2019 – July 2019: Associate, Morgan Lewis Stamford LLC
  • September 2017 – February 2019: Associate, Fortis Law Corporation
  • December 2016 – June 2017: Trainee, Aequitas Law LLP (for admission to the Singapore Bar)


  • 2017 – Qualified Advocate and Solicitor of the Supreme Court of Singapore
  • 2017 – Level 1, Chartered Financial Analyst Program
  • 2016 – Bachelor of Law (Cum Laude), Singapore Management University

Notable Experience

  • Venture debt and other private credit deals, such as acting for: (i) Swettenham Capital Pte. Ltd. as lender of a private credit facility of approximately S$55 million to re-finance and forestall the receivership sale of Link Hotel; (ii) the lenders for a syndicated private credit facility of approximately US$5 million in relation to the borrower’s proposed merger with a special purpose acquisition vehicle; (iii) the lenders for syndicated venture debt facilities to various FinTech and other Southeast Asian-based start-ups; and (iv) the borrowers for a syndicated private credit facility of approximately US$10 million for the expansion of its proprietary salary financing platform.
  • Initial public offerings and reverse takeovers of, amongst others: (i) Ardmore Medical Group (now known as Livingstone Health Ltd.) (Singapore Exchange, Catalist); (ii) SBI Offshore Limited (Singapore Exchange, Catalist); and (iii) AsiaPhos Limited (Singapore Exchange, Catalist).
  • Mergers and acquisitions, such as acting as Singapore counsel to Semperit Technische Produkte GmbH’s disposal of its medical business (comprising the manufacture, distribution and sale of medical examination and surgical gloves) to HARPS Global Pte Ltd for an enterprise value of approximately €115 million.
  • Fund formation and alternative investment products, such as acting as: (i) Singapore legal adviser for a private equity fund with a focus on high-growth disruptive technologies and a targeted fund size of US$100 million; and (ii) legal adviser for the securitisation of a luxury asset valued at approximately €5 million and the offering of said investment product to accredited investors.
  • Venture capital funding across many fundraising stages of different start-ups, such as a recent pre-Series A financing round for a semiconductor solutions and consultancy start-up with a pre-money valuation of S$25 million.


No items found.